{"entity":{"type":"insider","cik":"0001838539","url":"/insider/0001838539","json_url":"/insider/0001838539.json","name":"Schneider Eugene","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":15,"first":"2023-01-19","last":"2026-06-30","span_basis":"filed_date"},"name_variants":[{"name":"Schneider Eugene","source":"filing","n_filings":15,"first_seen":"2023-01-19","last_seen":"2026-06-30"}],"transactions":[{"id":5831916,"accession":"0000874015-26-000216","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000216","line_url":"/filing/0000874015-26-000216#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":81.046,"price_display":"81.05","price_state":"stated","total_value":2107196.0,"total_display":"2,107,196.00","total_whole":"2,107,196","shares_owned_after":77114.0,"shares_owned_after_display":"77,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5854741,"accession":"0000874015-26-000152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-26-000152","line_url":"/filing/0000874015-26-000152#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5812.0,"shares_display":"5,812","price_per_share":70.9715,"price_display":"70.97","price_state":"stated","total_value":412486.358,"total_display":"412,486.36","total_whole":"412,486","shares_owned_after":63890.0,"shares_owned_after_display":"63,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-19","filed_date":"2026-03-23","scope":"insider"},{"id":6145506,"accession":"0000874015-26-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000101","line_url":"/filing/0000874015-26-000101#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6179.0,"shares_display":"6,179","price_per_share":83.4487,"price_display":"83.45","price_state":"stated","total_value":515629.5173,"total_display":"515,629.52","total_whole":"515,630","shares_owned_after":69702.0,"shares_owned_after_display":"69,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":6216158,"accession":"0000874015-26-000071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-26-000071","line_url":"/filing/0000874015-26-000071#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9302.0,"shares_display":"9,302","price_per_share":75.59,"price_display":"75.59","price_state":"stated","total_value":703138.18,"total_display":"703,138.18","total_whole":"703,138","shares_owned_after":63890.0,"shares_owned_after_display":"63,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":4090255,"accession":"0000874015-25-000211","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000874015-25-000211","line_url":"/filing/0000874015-25-000211","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19658.0,"shares_display":"19,658","price_per_share":60.81091020958389,"price_display":"60.81","price_state":"stated","total_value":1195420.8729,"total_display":"1,195,420.87","total_whole":"1,195,421","shares_owned_after":58710.0,"shares_owned_after_display":"58,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-03","filed_date":"2025-09-04","scope":"insider","n_lines":2},{"id":4451745,"accession":"0000874015-25-000172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-25-000172","line_url":"/filing/0000874015-25-000172#line-1","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9549.0,"shares_display":"9,549","price_per_share":42.8004,"price_display":"42.80","price_state":"stated","total_value":408701.0196,"total_display":"408,701.02","total_whole":"408,701","shares_owned_after":51507.0,"shares_owned_after_display":"51,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-08-05","scope":"insider"},{"id":4126109,"accession":"0000874015-25-000080","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000080","line_url":"/filing/0000874015-25-000080#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1484.0,"shares_display":"1,484","price_per_share":32.1967,"price_display":"32.20","price_state":"stated","total_value":47779.9028,"total_display":"47,779.90","total_whole":"47,780","shares_owned_after":61056.0,"shares_owned_after_display":"61,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-03","scope":"insider"},{"id":4977280,"accession":"0000874015-25-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-25-000064","line_url":"/filing/0000874015-25-000064#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6523.0,"shares_display":"6,523","price_per_share":32.79,"price_display":"32.79","price_state":"stated","total_value":213889.17,"total_display":"213,889.17","total_whole":"213,889","shares_owned_after":58508.0,"shares_owned_after_display":"58,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":9201496,"accession":"0000874015-24-000197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000874015-24-000197","line_url":"/filing/0000874015-24-000197#line-1","is_derivative":false,"issuer_cik":"0001838539","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0001838539","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2106.0,"shares_display":"2,106","price_per_share":49.59,"price_display":"49.59","price_state":"stated","total_value":104436.54,"total_display":"104,436.54","total_whole":"104,437","shares_owned_after":47659.0,"shares_owned_after_display":"47,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-09-04","scope":"insider"},{"id":3105710,"accession":"0000874015-24-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000109","line_url":"/filing/0000874015-24-000109#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2071.0,"shares_display":"2,071","price_per_share":49.59,"price_display":"49.59","price_state":"stated","total_value":102700.89,"total_display":"102,700.89","total_whole":"102,701","shares_owned_after":49812.0,"shares_owned_after_display":"49,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-02","filed_date":"2024-02-02","scope":"insider"},{"id":3105699,"accession":"0000874015-24-000077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000077","line_url":"/filing/0000874015-24-000077#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5482.0,"shares_display":"5,482","price_per_share":50.417,"price_display":"50.42","price_state":"stated","total_value":276385.994,"total_display":"276,385.99","total_whole":"276,386","shares_owned_after":47850.0,"shares_owned_after_display":"47,850","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-18","scope":"insider"},{"id":2763518,"accession":"0000874015-24-000059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-24-000059","line_url":"/filing/0000874015-24-000059#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":53.4999,"price_display":"53.50","price_state":"stated","total_value":427999.2,"total_display":"427,999.20","total_whole":"427,999","shares_owned_after":38170.0,"shares_owned_after_display":"38,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-12","filed_date":"2024-01-17","scope":"insider"},{"id":8309185,"accession":"0000874015-23-000240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000240","line_url":"/filing/0000874015-23-000240#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":51.463,"price_display":"51.46","price_state":"stated","total_value":1286575.0,"total_display":"1,286,575.00","total_whole":"1,286,575","shares_owned_after":36052.0,"shares_owned_after_display":"36,052","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-28","scope":"insider"},{"id":7986699,"accession":"0000874015-23-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000095","line_url":"/filing/0000874015-23-000095#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1413.0,"shares_display":"1,413","price_per_share":40.6682,"price_display":"40.67","price_state":"stated","total_value":57464.1666,"total_display":"57,464.17","total_whole":"57,464","shares_owned_after":24946.0,"shares_owned_after_display":"24,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-07","scope":"insider"},{"id":8349757,"accession":"0000874015-23-000068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000874015-23-000068","line_url":"/filing/0000874015-23-000068#line-2","is_derivative":false,"issuer_cik":"0000874015","issuer_name":"IONIS PHARMACEUTICALS INC","issuer_ticker":"IONS","issuer_name_source":null,"issuer_url":"/issuer/0000874015","owner_cik":"0001838539","owner_name":"Schneider Eugene","owner_display_name":"Schneider Eugene","owner_url":"/insider/0001838539","role":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark":"O","role_mark_label":"Officer (EVP, Chf Clinical Develop Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chf Clinical Develop Ofcr","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4752.0,"shares_display":"4,752","price_per_share":39.5732,"price_display":"39.57","price_state":"stated","total_value":188051.8464,"total_display":"188,051.85","total_whole":"188,052","shares_owned_after":22326.0,"shares_owned_after_display":"22,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000874015","name":"IONIS PHARMACEUTICALS INC","url":"/issuer/0000874015","role":"Officer (EVP, Chf Clinical Develop Ofcr)","n_filings":15,"first_seen":"2023-01-19","last_seen":"2026-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838539","retrieved_at":"2026-08-27T10:16:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}